The FDA approved dupilumab for children aged 2 to 11 years with uncontrolled CSU—the first biologic for this pediatric population. The approval extends the indication previously approved in April 2025 ...
The authors examined experiences with Pennsylvania’s implementation of opioid settlement funds, identifying 7 themes and ...
National Prescription Drug Take Back Day provides twice-yearly, no-questions-asked medication disposal; the April 2026 event ...
The AMCP 2026 annual meeting brought together managed care professionals in Music City last week. The organization returned ...
Parth Desai, MBBS, MD, discusses how clinicians balance liquid biopsy, tissue testing, and fast-start chemo to personalize ...
Tuan Vu, MD, professor and division director of Neuromuscular Medicine & Electromyography at USF Health, discussed the safety ...
Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...
A nested case-control analysis within ASPREE matched incident CVD cases to controls and modeled longitudinal cognition to detect pre-event trajectory differences across validated domain-specific ...
FDA approves doravirine/islatravir, a once-daily, 2-drug, single-tablet HIV regimen showing noninferior efficacy to standard ...
Although surgeries to treat cataracts are deemed successful for most patients under the Merit-Based Incentive Payment System ...
Teplizumab-mzwv is the first disease-modifying therapy available for children as young as 1 year diagnosed with ...
Transformed Medicaid TAF analyses evaluated OUD diagnosis, MOUD receipt, 180-day continuation, and OUD-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results